Segui
Richard Baker Jones
Richard Baker Jones
Independent biotechnology professional
Email verificata su uchicago.edu
Titolo
Citata da
Citata da
Anno
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
1947*2021
10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial
A Halliday, M Harrison, E Hayter, X Kong, A Mansfield, J Marro, H Pan, ...
The Lancet 376 (9746), 1074-1084, 2010
11202010
A quantitative protein interaction network for the ErbB receptors using protein microarrays
RB Jones, A Gordus, JA Krall, G MacBeath
Nature 439 (7073), 168-174, 2005
9342005
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...
Medrxiv, 2021.06. 15.21258542, 2021
515*2021
Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4
C Yu, F Wang, M Kan, C Jin, RB Jones, M Weinstein, CX Deng, ...
Journal of Biological Chemistry 275 (20), 15482-15489, 2000
4332000
System and method for detecting fraudulent transactions
J Hillmer, R Jones, C Gessner, C Johnston, K Lewis, S Deshpande
US Patent App. 10/298,814, 2003
3852003
Innate immune and chemically triggered oxidative stress modifies translational fidelity
N Netzer, JM Goodenbour, A David, KA Dittmar, RB Jones, JR Schneider, ...
Nature 462 (7272), 522-526, 2009
3832009
System and method for detecting fraudulent transactions
JM Hillmer, RA Jones, CM Gessner, CS Johnston, KR Lewis Jr, ...
US Patent 6,714,918, 2004
3352004
Start-up, operation, monitoring and control of high-rate anaerobic treatment systems
RF Hickey, WM Wu, MC Veiga, R Jones
Water Science and Technology 24 (8), 207-255, 1991
3321991
Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study
WJ Sandborn, S Travis, L Moro, R Jones, T Gautille, R Bagin, M Huang, ...
Gastroenterology 143 (5), 1218-1226. e2, 2012
3222012
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
SPL Travis, S Danese, L Kupcinskas, O Alexeeva, G D'Haens, PR Gibson, ...
Gut 63 (3), 433-441, 2014
3092014
Fournier’s syndrome: necrotizing subcutaneous infection of the male genitalia
RB Jones, JV Hirschmann, GS Brown, JA Tremann
The Journal of urology 122 (3), 279-282, 1979
2911979
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...
The Lancet 400 (10349), 359-368, 2022
2692022
A theoretical approach to the deformation of honeycomb based composite materials
FK Abd El-Sayed, R Jones, IW Burgess
Composites 10 (4), 209-214, 1979
2431979
Systems analysis of EGF receptor signaling dynamics with microwestern arrays
MF Ciaccio, JP Wagner, CP Chuu, DA Lauffenburger, RB Jones
Nature methods 7 (2), 148-155, 2010
2402010
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial
SM Lee, I Khan, S Upadhyay, C Lewanski, S Falk, G Skailes, E Marshall, ...
The lancet oncology 13 (11), 1161-1170, 2012
2182012
Systematic discovery of TLR signaling components delineates viral-sensing circuits
N Chevrier, P Mertins, MN Artyomov, AK Shalek, M Iannacone, ...
Cell 147 (4), 853-867, 2011
2152011
A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain
J Wojcik, O Hantschel, F Grebien, I Kaupe, KL Bennett, J Barkinge, ...
Nature structural & molecular biology 17 (4), 519-527, 2010
2062010
Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs
S Ye, Y Luo, W Lu, RB Jones, RJ Linhardt, I Capila, T Toida, M Kan, ...
Biochemistry 40 (48), 14429-14439, 2001
1912001
An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells
I Neganova, F Vilella, SP Atkinson, M Lloret, JF Passos, T Von Zglinicki, ...
Stem Cells 29 (4), 651-659, 2011
1762011
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20